Event has finished,
See you next year!

Indo US Bridging RARE Summit 2023

Connecting the Global Rare Disease Community

In the 40 years since the Orphan Drug Act was legislated in the USA, there is a growing understanding of the importance of rare diseases that affect over 30 million Americans. While the situation in Europe is similar, no such awareness exists in many parts of the world such as India which is home to over a quarter of the world’s population. It is time to change that, for the 1.5 billion people in India, and the 8 billion people across the world.

The Bridging RARE Summit 2023 brings together key leaders representing all stakeholders of rare diseases from across the world with a specific focus on the US, and the Indian subcontinent.

Cross Border Patient Engagement

Care Pathways: Screening, Diagnosis, & Treatment options

Digitization of Rare Diseases - Registries, Emerging Markets

DEI & Globalization for Orphan Drugs

Orphan Drug Clinical Trials

Regulatory pathways for Orphan Drugs

Indo US Bridging RARE Summit 2023 is a Hybrid Event

Live and in-person at Van Metre Hall, George Mason University

Registrations Details

Fee details chart for the Indo-US Bridging RARE Summit 2023.

 

Registration fee chart for the Indo-US Bridging RARE Summit 2023, Gala & Awards ceremony.
  • Please note that only the Indo US Bridging RARE Summit sessions can be attended virtually. The Gala and Awards Ceremony is an in person only event, and will require your presence at the venue
  • *Valid only if the ticket is purchased along with Summit registration. This rate will not be applicable if tickets are purchased separately at any later point in time.
  • Please note Discount is NOT applicable on Gala Ticket.

Gala and Awards Ceremony

Gala and Awards Ceremony

Indo US Bridging RARE Summit Gala Dinner & Award Ceremony

Agenda

*All times are based on US Eastern Time

Registration and Breakfast (7:00 am to 8:00 am)

Welcome Note

Amy Adams, PhD Institute for Biohealth Innovation, George Mason University

John Newby, JD Virginia Bio

Why IndoUSrare? Why Now? Why are we here?

Harsha Rajasimha, MS, PhD Indo US Organization for Rare

IndoUSrare Programs and Impact

Nisha Venugopal, PhD Indo US Organization for Rare Diseases

Patient/Caregiver Keynote (US)

Naveen Baweja, MBA and Priyanka Kakkar Cure ADSSL1

Patient/Caregiver Keynote (India)

Gautam Dongre National Alliance of Sickle Cell Organizations (NASCO)

Panel Discussion

Samir Sethi Indian Rett Syndrome Foundation (IRSF)

Suyog Sathe International Gaucher Alliance & Lysosomal Storage Diseases Support Society India (LSDSS-India)

Dorothea Lantz, MPA Prader Willi Syndrome Association

Alison Bones, BBA T.E.A.M. for Travis

Networking Break

Plenary Keynote

K Thangaraj, PhD Centre for DNA Fingerprinting and Diagnostics (CDFD)

Panel Discussion

  • How to engage and collaborate better?
  • Diversity, Equity, Inclusion, and Access (DEIA) in the context of the Indian Community
  • Sickle Cell Disease (hematological disorders), Neuromuscular dystrophies, Lysosomal storage disorders, Autoimmune, Dermatological, Leukodystrophies, and other rare disorders prevalent among the Indian diaspora.
  • Panel discussion

Maria G. Della Rocca, MS, PMP Global Genes

Teresa Ginger Davis Sickle Cell/Thalassemia Patients Network

Bonnie Schneider IGA Nephropathy Foundation

Lunch (12:00pm to 1:00pm)

  1. Rare Epilepsies - Room 120: Gabi Conecker (Decoding Developmental Epilepsies (DDE)), Prof. Sheffali Gulati, MD, FRCPCH (UK), FAMS, FIAP, FIMSA (AIIMS - Delhi)
  2. Undiagnosed Diseases - Room 118: Marlene Soto Riera (Helping Swans Co.), Shifali Gupta, MD (Post Graduate Institute of Medical Education and Research)
  3. Disease "Avatars" & Preclinical Research - Room 113: Srujana Cherukuri, PhD (Noble Life Sciences), Srinath TL, PhD (GenoPhe Biotech Pvt Ltd)
  4. Living with a Rare Disease - Room 111: Dorothea Lantz, Cristol Barret O’Loughlin, Suyog Sathe

Plenary Keynote

Madhulika Kabra, MD All India Institute of Medical Sciences, New Delhi (AIIMS-Delhi)

Harsh Sheth, PhD FRIGE - Institute of Human Genetics

Panel Discussion

Ashish Gupta, MD University of Minnesota

Tiina Urv, MD National Center for Advancing Translational Sciences (NCATS, NIH)

Tamanna Roshan Lal, MD Uncommon Cures

Networking Break

Plenary Keynote

Subha Madhavan, PhD Pfizer, Inc.

Panel Discussion

Sophia Zilber Cure Mito

Paul Mehta, MD Centers for Disease Control and Prevention (CDC)

Dr. Amlin Shukla Indian Council of Medical Research (ICMR)

Networking Happy Hour (4:30 pm to 6:00 pm)

Live Music Performance: Sasanka Sreedevi Naresh Briar Woods High School

Parent/Caregiver of a Rare Disease: Ms. Urvi Bham

Diagnostic Odyssey in the DMV area: Ms. Geetha Bhat

A Short Video About Indo US RARE

Importance of legislative advocacy: Krystle Veda Kaul, PMP Candidate for Congress, VA District 10

Inaugural Keynote: Vikram Karnani, MBA Horizon Therapeutics

Abbey Meyers Khushi Bridging RARE Awards Ceremony:
Honoree 1: Dr. Ishwar Chander Verma Sir Ganga Ram Hospital
Honoree 2: Dr William Gahl, Undiagnosed Disease Network International (UDNI)

Congratulatory Message: Abbey S. Meyers, PhD Founder, NORD

Letter of Recognition and Support from Congressman Gerald Connolly: Sreelakshmi Vayal Veettil Intern

A tribute to Indo US RARE
A dance production: Dr. Mani and Anagha Sreenivas Nupura Naadam Dance Academy

Entertainment and Gala Dinner

Sasanka Sreedevi NareshBriar Woods High School

Ms. Urvi Bham

Ms. Geetha Bhat

Krystle Veda Kaul, PMPCandidate for Congress, VA District 10

Vikram Karnani, MBA Horizon Therapeutics

Abbey S. Meyers, PhD Founder, NORD

Sreelakshmi Vayal VeettilIntern

Dr. Mani and Anagha SreenivasNupura Naadam Dance Academy

Donor and Volunteer Recognition

Narayanan Govindarajan, MS IndoUSrare

Ramya T. Karur, MScIndoUSrare

Juhi Naithani, MBAIndoUSrare and bGlobal Consulting

Dance Floor is Open
Close of Day 1 (9:30 pm)

Networking Breakfast (7:30 am to 8:20 am)

Recap of Day 1

Reena Kartha, Ph.D

Keynote Address (US)

Peter Marks, MD, PhD US Food and Drug Administration (US FDA)

Keynote Address (India)

Dr. L SwasticharanDirectorate General of Health Services, India

Rare Disease Revolution: Bridging Technology, Equity, and Therapies

Isaac Rodriguez-Chavez, PhD4Biosolutions Consulting

What are the pathways for rare disease drugs in India?

Bhaskar Sonowal, MBBS, MBA HED Healthcare

Gene Therapies

Sukumar Nagendran, MDTAYSHA Therapeutics

Global product development: Gaps and considerations

Sumati Nambiar, MD, MPH

Networking Break

Panel Discussion

Moke Sharma, MBABristol Myers Squibb (BMS)

Rusty Clayton, DO Larimar Therapeutics

Pankaj Bhargava, MD AshiBio

Harsha Rajasimha, PhD Jeeva Clinical Trials

Networking Break

Panel Discussion

  • What are current strategies for large and small companies?
  • Why is there a lack of emphasis on geographies other than the US and Western Europe?
  • What can be done to change this scenario?

Meredith Manning, MBA PharmaEssentia Corp

Mike Blum, MBA, Homology Medicines

Matthew Pauls, MBA, JD, Savara,Inc.

Neil Kumar, PhD BridgeBio

Lunch (12:30 pm to 1:30 pm)

  • Mental Wellbeing in Rare Diseases - Cristol O Loughlin
  • AI and Data Sharing - Subha Madhavan, PhD
  • Environmental Factors Affecting Rare Diseases - Paul Mehta, MD
  • Startup Ecosystem in Rare Diseases - Supriya Doshi, BDS, MPH, MBA, FAHM
  • Newborn Screening, Diagnosis - Reena Kartha, MS PhD, Harsh Sheth, PhD
  • Global Clinical Trial Operations for Orphan Drugs - Rusty Clayton DO, Harsha Rajasimha, PhD
  • Global Commercialization of Orphan Products - Anish Bhatnagar,MD, Neil Kumar, PhD
  • Global Regulatory Strategies - Isaac Rodriguez-Chavez, PhD, Bhaskar Sonowal, MBBS
  • Policy Advocacy - Impact of Recent Legislations and Policy Guidelines - Frank Sasinowski,JD, MPH
  • Standard of Care Pathways, Clinical Research as a Care Option (CRAACO) - Tamanna RoshanLal, MD
  • Rare Diseases in Virginia and the BioHealth Capital Region - John Newby, JD, Amy Adams, PhD

Plenary Keynote

Prof. Sheffali Gulati, MD, FRCPCH (UK), FAMS, FIAP, FIMSA All India Institute of Medical Sciences (AIIMS), New Delhi

India’s population history enables discovery and development of therapies for inherited disorders

Sekar Seshagiri, PhD MedGenome Inc., and AntlerA Therapeutics

Panel Discussion

Dean Suhr, BS MLD Foundation

Mohua Chakraborty Choudhury, PhD Johns Hopkins University

Theresa Strong, PhD Foundation for Prader-Willi Research (FPWR)

Avni Santani, PhD OpusGenomics

Volunteer Recognition

  • ART4RARE
  • Youth Ambassadors
  • Advocacy
  • Communications

Nisha Venugopal, PhD Indo US Organization for Rare Diseases

Networking (3:00 pm to 4:00 pm)

Pre-arranged Bus tours of local attractions and counties to showcase resources and capabilities in the BHCR region.

Close of Day 2 (4:00 pm)

Keynote Speakers


Ms. Meredith Manning, President – The Americas Pharma Essentia USA Corporation.

Peter Marks, MD, PhD

Director Center for Biologics Evaluation and Research (CBER) FDA

Dr. L Swasticharan

Additional DDG and Director (EMR) Directorate General of Health Services Ministry of Health and Family Welfare, Govt of India
Ms. Meredith Manning, President – The Americas Pharma Essentia USA Corporation.

Vikram Karnani, MS, MBA

Executive Vice President and President, Global Commercial Operations and Medical Affairs Horizon Therapeutics

Special Address


AbbeySMeyers

Abbey S Meyers, PhD

Founder and past President National Organization for Rare Disorders (NORD)

Our Speakers


Mr. Gautam Dongre, Secretary, National Alliance of Sickle Cell Organizations (NASCO), India.

Gautam Dongre

Secretary, National Alliance of Sickle Cell Organizations (NASCO), India.  
Mr. Naveen Baweja, Co-founder, Cure ADSSL1.

Naveen Baweja

Co-founder Cure ADSSL1

Mohua Chakraborty Choudhury, PhD

MPH student at Johns Hopkins University Visiting Scholar at IISc

Teresa Ginger Davis

President Sickle Cell/Thalassemia Patients Network Inc.

Ashish Gupta MD, MPH

Assistant Professor Pediatric Blood and Marrow Transplantation & Cellular Therapy University of Minnesota
Mathew Pauls

Mathew Pauls, MBA, JD

CEO Savara,Inc.

Theresa Strong, PhD

Co-founder and Director of Research Programs Foundation for Prader-Willi Research (FPWR)
Ms. Priyanka Kakkar, Co-founder, Cure ADSSL1.

Priyanka Kakkar

Co-founder Cure ADSSL1
Ms. Meredith Manning, President – The Americas Pharma Essentia USA Corporation.

Meredith Manning

President – The Americas PharmaEssentia USA Corporation
Sophia Zilber

Sophia Zilber

Associate Director, Statistical Programming Cure Mito Foundation
Ms. Meredith Manning, President – The Americas Pharma Essentia USA Corporation.

Paul Mehta, MD

Principal Investigator National ALS Registry, CDC/ATSDR
Mr. Suyog S., Director, International Gaucher Alliance (IGA) Secretary, Lysosomal Storage Disorders Support Society (LSDSS) India.

Suyog S

Director, International Gaucher Alliance (IGA) Secretary, Lysosomal Storage Disorders Support Society (LSDSS) India
Ms. Meredith Manning, President – The Americas Pharma Essentia USA Corporation.

Bonnie Schneider

Director & Co-Founder IgA Nephropathy Foundation
Ms. Meredith Manning, President – The Americas Pharma Essentia USA Corporation.

Samir Sethi

President Indian Rett Syndrome Foundation
Dr. Harsh Sheth, Assistant Professor & Head Advanced Genomic Technologies Division, FRIGE Institute of Human Genetics, India.

Harsh Sheth, PhD

Assistant Professor & Head Advanced Genomic Technologies Division, FRIGE Institute of Human Genetics, India
Cristol Barrett O'Loughlin

Cristol Barrett O'Loughlin

Founder and CEO Angel Aid
Dorothea Lantz, MPA

Dorothea Lantz, MPA

Director of Community Engagment Prader-Willi Syndrome Association | USA
Maria Della Rocca

Maria Della Rocca, MS, PMP

Sr. Director, Support & Education Programs Global Genes
Nikhil Bumb

Nikhil Bumb, MS, MBA

Managing Director FSG
TamannaTannan

Tamanna Roshan Lal, MB ChB

Chief Medical Officer Uncommon Cures
Subha Madhavan, PhD

Subha Madhavan, PhD

VP & Global Head of AI/ML & Digital Sciences Pfizer R&D
Isaac Rodrigues- Chavez

Isaac Rodriguez-Chavez, PhD

Principal Consultant & CEO 4Biosolutions Consulting

Rusty Clayton, DO

Chief Medical Officer Larimar Therapeutics, Inc.
Ms. Meredith Manning, President – The Americas Pharma Essentia USA Corporation.

Parthiban Srinivasan

- -
Ms. Meredith Manning, President – The Americas Pharma Essentia USA Corporation.

Marlene Soto-Riera

RARE Parent, Caregiver & Advocate Helping Swans Co.
Ms. Meredith Manning, President – The Americas Pharma Essentia USA Corporation.

Srinath TL, PhD

CEO & Founding Director GenoPhe Biotech Pvt. Ltd.
Mike Blum

Michael Blum MBA

Vice President, Commercial Strategy Homology Medicines, Inc.
Dean Suhr

Dean Suhr, BS

President MLD Foundation
Alison Bones

Alison Bones, BBA

President and CEO T.E.A.M. 4 Travis (Together Ending Asplenia Mortality)
Mokesharma

Moke Sharma, MBA

SVP, Head of Global Development Operations Bristol Myers Squibb
Pankaj Bhargava

Pankaj Bhargava, MD

CEO ashibio
Pankaj Bhargava

Neil Kumar, PhD

CEO and Founder BridgeBio Pharma
Pankaj Bhargava

Prof. Sheffali Gulati, MD, FRCPCH (UK), FAMS, FIAP, FIMSA

Professor, Program Director, DM Pediatric Neurology Programme AIIMS, Delhi
Pankaj Bhargava

Gabi Conecker, MPH

Executive Director and Co-Founder Decoding Development Epilepsies

Shifali Gupta, MD

- Post Graduate Institute of Medical Education and Research

Dr. Amlin Shukla

Scientist D Indian Council of Medical Research (ICMR)

Tiina Urv, PhD

Program Director Rare Diseases Clinical Research Network (RDCRN)

Sarah Friedhoff

Director Patient Advocacy at Astria Therapeutics

Sukumar Nagendran, MD

President and Head of R&D TAYSHA Therapeutics

Somasekhar Seshagiri, MS, PhD

Chief of Genomics and Informatics MedGenome Inc.

Sumati Nambiar MD MPH

Summit Planning Committee


Ms. Amy Adams, Ph.D.,Institute for Biohealth Innovation, George Mason University.

Amy Adams, Ph.D.

Institute for Biohealth Innovation, George Mason University
Mr. Rich Bendis, BioHealth Innovation and BioHealth Capital Region Forum.

Rich Bendis

BioHealth Innovation and BioHealth Capital Region Forum
Mr. Anish Bhatnagar, MD, IndoUSrare and Soleno Therapeutics.

Anish Bhatnagar, MD

IndoUSrare and Soleno Therapeutics
Ms. Madhulika Kabra, MD, All India Institute of Medical Sciences (AIIMS, Delhi).

Madhulika Kabra, MD

All India Institute of Medical Sciences (AIIMS, Delhi)
Ms. Reena Kartha, MS, Ph.D., IndoUSrare and Center for Orphan Drug Research, UMN.

Reena Kartha, MS, PhD

IndoUSrare and Center for Orphan Drug Research, UMN
Ms. Juhi Naithani, MBA, IndoUSrare and bGlobal Consulting.

Juhi Naithani, MBA

IndoUSrare and bGlobal Consulting
Mr. John Newby, JD, Virginia Bio.

John Newby, JD

Virginia Bio
Mr. Harsha Rajasimha, MS, Ph.D., IndoUSrare and Jeeva Informatics Solutions.

Harsha Rajasimha, MS, PhD

IndoUSrare and Jeeva Informatics Solutions
Mr. Frank Sasinowski, MPH, JD, IndoUSrare and Hyman Phelps McNamara PC.

Frank Sasinowski, JD, MPH

IndoUSrare and Hyman Phelps McNamara PC
Mr. Bhaskar Sonowal, MBBS, MBA, IndoUSrare and HED Healthcare.

Bhaskar Sonowal, MBBA, MBA

IndoUSrare and HED Healthcare
Mr. K Thangaraj, Ph.D.,Centre for DNA Fingerprinting and Diagnostics (CDFD)

K Thangaraj, PhD

Centre for DNA Fingerprinting and Diagnostics (CDFD)

Organizing Secretariat

Nara Govindarajan, MS

IndoUSrare

Nisha Venugopal, Ph.D.

IndoUSrare

Annaliess Trommatter

Institute for Biohealth Innovation, GMU

Ramya Karur

IndoUSrare

Katie Maney

Institute for Biohealth Innovation, GMU

Poster Presentation

Present Your Research at the Indo US Bridging RARE Summit 2023

This is an excellent opportunity for you to showcase your work and expand your collaborative network by interacting with rare disease stakeholders including our eminent speakers and panelists from US and India.

We welcome Posters across a broad range of themes including:

  • Cross Border Patient Engagement
  • Indo-US Comparisons in Care Pathways - Screening, Diagnosis, & Treatment Options
  • Data Privacy and Governance Across Borders
  • Clinical Trials for Orphan Drugs
  • Advances in Regulatory Pathways for Orphan Products
  • DEIA and Globalization for Orphan Drug Research
  • Others

Important Timelines to make note of:

  • Abstract Submissions - Oct 10th 5pm ET
  • Committee Decisions - Oct 15th 5 pm ET
  • Presenter Acceptance deadline - Oct 10th 5 pm ET
  • Digital Poster Submission - Oct 15th 5pm ET

Gold Sponsors

Silver Sponsors

Logo of BFS.
Logo of larimar.
Logo of BFS.

Sponsors

Souvenir Book

The Indo US Bridging RARE Summit Souvenir will be distributed to all attendees. It showcases speaker profiles, the meeting agenda and special sessions, Sponsors, leadership messages, photographs, Sponsor and exhibitor information, and much more.


Download Souvenir Booklet

Specifications

The souvenir book will be designed to have a final size of 8.5”x 11” which will include a ½” border all around. Please follow the below-listed specifications while submitting your ad.

File Size

  • Full page ad: 7.5” x 10”
  • Half page ad: 3” X 5”

File Format

  • High-resolution PDF or JPEG ( minimum 300 DPI resolution)
  • All color files must be created using CMYK
  • All files should have embedded fonts.

Files that do not meet these requirements will not be accepted. Quality of printing will depend upon the sharpness of the images used.

Submissions

  • Ads may also be emailed to summit@indousrare.org

LAST DATE FOR SUBMISSIONS: 10 October 2023